KD Logo

HIMS stock rated a Buy by Needham

Hims & Hers Health Inc’s recently made public that its Officer Melissa Baird acquired Company’s shares for reported $1.14 million on Oct 07 ’24. In the deal valued at $19.44 per share,58,750 shares were bought.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Dudum Andrew sold 188,888 shares, generating $3,433,162 in total proceeds. Upon selling the shares at $18.18, the Chief Executive Officer now owns 67,015 shares.

Before that, Dudum Andrew sold 144,444 shares. Hims & Hers Health Inc shares valued at $2,631,394 were divested by the Chief Executive Officer at a price of $18.22 per share. As a result of the transaction, Dudum Andrew now holds 651,046 shares, worth roughly $12.66 million.

Needham initiated its Hims & Hers Health Inc [HIMS] rating to a Buy in a research note published on August 22, 2024; the price target was $24. A number of analysts have revised their coverage, including Imperial Capital’s analysts, who decreased its forecast for the stock in early August from “an Outperform” to “an In-line”. Citigroup also remained covering HIMS and has decreased its forecast on May 22, 2024 with a “Neutral” recommendation from previously “Buy” rating. Jefferies revised its rating on April 16, 2024. It rated HIMS as “a Hold” which previously was an “a Buy”.

Price Performance Review of HIMS

On Monday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock jump 10.08% to $19.44. Over the last five days, the stock has gained 5.54%. Hims & Hers Health Inc shares have risen nearly 118.43% since the year began. Nevertheless, the stocks have risen 208.08% over the past one year. While a 52-week high of $25.74 was reached on 06/18/24, a 52-week low of $5.65 was recorded on 01/05/24. SMA at 50 days reached $16.64, while 200 days put it at $15.18.

Levels Of Support And Resistance For HIMS Stock

The 24-hour chart illustrates a support level at 18.70, which if violated will result in even more drops to 17.97. On the upside, there is a resistance level at 20.08. A further resistance level may holdings at 20.73. The Relative Strength Index (RSI) on the 14-day chart is 63.62, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.44, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 12.91%. Stochastics %K at 59.61% indicates the stock is a holding.

How much short interest is there in Hims & Hers Health Inc?

A steep rise in short interest was recorded in Hims & Hers Health Inc stocks on 2024-09-13, growing by 3.49 million shares to a total of 26.54 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 23.04 million shares. There was a rise of 13.17%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on April 10, 2024 when Canaccord Genuity began covering the stock and recommended ‘”a Buy”‘ rating along with a $20 price target.

Most Popular